Conestoga Capital Advisors LLC grew its position in Balchem Corporation (NASDAQ:BCPC) by 49.1% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 533,894 shares of the basic materials company’s stock after acquiring an additional 175,850 shares during the quarter. Balchem Corporation makes up approximately 1.9% of Conestoga Capital Advisors LLC’s holdings, making the stock its 25th largest position. Conestoga Capital Advisors LLC owned 1.67% of Balchem Corporation worth $43,400,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Riverhead Capital Management LLC increased its holdings in shares of Balchem Corporation by 94.9% in the 2nd quarter. Riverhead Capital Management LLC now owns 1,364 shares of the basic materials company’s stock valued at $106,000 after acquiring an additional 664 shares during the last quarter. Victory Capital Management Inc. increased its holdings in shares of Balchem Corporation by 17.6% in the 2nd quarter. Victory Capital Management Inc. now owns 2,130 shares of the basic materials company’s stock valued at $166,000 after acquiring an additional 319 shares during the last quarter. Sei Investments Co. increased its holdings in shares of Balchem Corporation by 117.9% in the 2nd quarter. Sei Investments Co. now owns 2,465 shares of the basic materials company’s stock valued at $191,000 after acquiring an additional 1,334 shares during the last quarter. Turner Investments LLC increased its holdings in shares of Balchem Corporation by 25.0% in the 2nd quarter. Turner Investments LLC now owns 2,500 shares of the basic materials company’s stock valued at $194,000 after acquiring an additional 500 shares during the last quarter. Finally, Oliver Luxxe Assets LLC bought a new stake in shares of Balchem Corporation in the 3rd quarter valued at approximately $205,000. Institutional investors and hedge funds own 84.86% of the company’s stock.
Separately, BidaskClub downgraded Balchem Corporation from a “sell” rating to a “strong sell” rating in a report on Monday, July 31st.
Shares of Balchem Corporation (BCPC) traded down 0.81% on Wednesday, reaching $83.61. The company had a trading volume of 17,642 shares. The company’s 50-day moving average is $81.23 and its 200 day moving average is $78.96. The firm has a market capitalization of $2.67 billion, a PE ratio of 43.32 and a beta of 1.12. Balchem Corporation has a 12 month low of $67.71 and a 12 month high of $89.50.
Balchem Corporation (NASDAQ:BCPC) last issued its earnings results on Friday, August 4th. The basic materials company reported $0.64 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.63 by $0.01. Balchem Corporation had a return on equity of 14.99% and a net margin of 10.99%. The business had revenue of $147.08 million during the quarter. Equities analysts forecast that Balchem Corporation will post $2.47 earnings per share for the current year.
COPYRIGHT VIOLATION NOTICE: “Balchem Corporation (BCPC) Shares Bought by Conestoga Capital Advisors LLC” was originally published by Community Financial News and is owned by of Community Financial News. If you are accessing this piece of content on another publication, it was stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece of content can be viewed at https://www.com-unik.info/2017/11/01/balchem-corporation-bcpc-shares-bought-by-conestoga-capital-advisors-llc.html.
Balchem Corporation Profile
Balchem Corporation is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization and industrial markets. The Company operates in four segments: Human Nutrition & Health, Animal Nutrition & Health, Specialty Products and Industrial Products.
What are top analysts saying about Balchem Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Balchem Corporation and related companies.